[ad_1]
World regions. National burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795–820.
Wang YJ, Li ZX, Gu HQ, Zhai Y, Zhou Q, Jiang Y, Zhao XQ, Wang YL, Yang X, Wang CJ, et al. China stroke statistics: an update of the 2019 report by the National Center for Medical Quality Control of Neurological Diseases, China National Clinical Research Center for Neurological Diseases, China Stroke Association, National Center for Chronic Noncommunicable Diseases Prevention and Control, China Center for Disease Prevention and Control, and Global Neuroscience and Stroke Collaborative Institute. Stroke Vasc Neurol. 2022;7(5):415–50.
Guerrero-Romero F, Villalobos-Molina R, Jiménez-Flores JR, Simental-Mendia LE, Méndez-Cruz R, Murguía-Romero M, Rodríguez-Morán M. Fasting triglycerides and glycemic index as diagnostic tests for insulin resistance in young adults. Arch Med Res. 2016;47(5):382–7.
Yang Y, Huang X, Wang Y, Leng L, Xu J, Feng L, Jiang S, Wang J, Yang Y, Pan G, et al. Impact of triglyceride-glucose index on ischemic stroke: a systematic review and meta-analysis. Cardiovasc Diabetol. 2023;22(1):2.
Zhou H, Ding X, Lan Y, Chen S, Wu S, Wu D. Diverse trajectories of cardiovascular disease, triglyceride-glucose index, and lifestyle: a cohort study. Cardiovasc Diabetol. 2023;22(1):341.
Zhao Q, Zhang TY, Cheng YJ, Ma Y, Xu YK, Yang JQ, Zhou YJ. Triglyceride-glucose index as a surrogate marker of insulin resistance to predict cardiovascular outcomes in nondiabetic patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. J Atheroscler Thromb. 2021;28(11):1175–94.
Wu S, Huang Z, Yang X, Zhou Y, Wang A, Chen L, Zhao H, Ruan C, Wu Y, Xin A, et al. Prevalence of ideal cardiovascular health and its relationship with 4-year cardiovascular events in an industrial city in northern China. Circ Cardiovasc Qual Outcomes. 2012;5(4):487–93.
Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, Martínez-Abundis E, Ramos-Zavala MG, Hernández-González SO, Jacques-Camarena O, Rodríguez-Morán M. Triglyceride-glucose product, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–51.
Ding X, Fang W, Yuan X, Seery S, Wu Y, Chen S, Zhou H, Wang G, Li Y, Yuan X, et al. Association of healthy lifestyle trajectories with cardiovascular disease incidence and all-cause mortality: a large prospective Chinese cohort study. Front Cardiovasc Med. 2021;8:790497.
Wu S, An S, Li W, Lichtenstein AH, Gao J, Kris-Etherton PM, Wu Y, Jin C, Huang S, Hu FB, et al. Associations between cardiovascular health score trajectories and incident cardiovascular disease. JAMA Netw Open. 2019;2(5):e194758.
Reynolds K, Gu D, Whelton PK, Wu X, Duan X, Mo J, He J. Prevalence and risk factors of overweight and obesity in China. Obes (Silver Spring). 2007;15(1):10–8.
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation for estimating glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.
Force WT. Stroke-1989. Recommendations for the prevention, diagnosis, and treatment of stroke. Report of the WHO Task Force on Stroke and Other Cerebrovascular Disorders. Stroke. 1989;20(10):1407–31.
Nagin DS, Jones BL, Passos VL, Tremblay RE. Group-based multi-trajectory modeling. Stat Methods Med Res. 2018;27(7):2015–23.
Nagin DS, Tremblay RE. Developmental trajectory groups: Fact or useful statistical fiction? Criminology. 2005;43(4):873–904.
Wang X, Feng B, Huang Z, Cai Z, Yu X, Chen Z, Cai Z, Chen G, Wu S, Chen Y. Association between cumulative exposure to triglyceride-glucose index and ischemic stroke: a 9-year prospective study in the Kailuan cohort. Cardiovasc Diabetol. 2022;21(1):66.
Li H, Zuo Y, Qian F, Chen S, Tian X, Wang P, Li X, Guo X, Wu S, Wang A. Variation in triglyceride-glucose index and incident cardiovascular disease: a prospective cohort study. Cardiovasc Diabetol. 2022;21(1):105.
Tian X, Zuo Y, Chen S, Meng X, Chen P, Wang Y, Wu S, Luo Y, Wang A. Different triglyceride-glucose trajectories are associated with distinct portions of risk for incident cardiovascular disease in normal-weight adults. Am Heart J. 2022;248:63–71.
Jiao Y, Su Y, Shen J, Hou X, Li Y, Wang J, Liu B, Qiu D, Sun Z, Chen Y, et al. Evaluation of the long-term prognostic value of triglyceride-glucose index in elderly patients with acute coronary syndrome: a cohort study. Cardiovasc Diabetol. 2022;21(1):3.
Lee SH, Han K, Yang HK, Kim HS, Cho JH, Kwon HS, Park YM, Cha BY, Yoon KH. A new criterion for identifying metabolically obese but normal weight individuals using triglyceride-glucose product. Nutr Diabetes. 2015;5(4):e149.
Investigator DT. Effect of rosiglitazone on the incidence of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial. Lancet. 2006;368(9541):1096–105.
Kernan WN, Viscoli CM, Furie KL, Young LH, Inzucchi SE, Gorman M, Guarino PD, Lovejoy AM, Peduzzi PN, Conwit R. Pioglitazone after ischemic stroke or transient ischemic attack. N Engl J Med. 2016;374(14):1321–31.
Patel TP, Rawal K, Bagchi AK, Akolkar G, Bernardes N, Dias DS, Gupta S, Singal PK. “Insulin resistance: an additional risk factor for the development of cardiovascular disease in type 2 diabetes.” Heart Fail Rev. 2016;21:11–23.
Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker of cardiovascular disease: current status and limitations. Cardiovasc Diabetol. 2022;21(1):68.
Li J, Dong Z, Wu H, Liu Y, Chen Y, Li S, Zhang Y, Qi X, Wei L. Triglyceride-glucose index is associated with atherosclerosis in patients with symptomatic coronary artery disease with or without diabetes and hyperlipidemia. Cardiovasc Diabetol. 2023;22(1):224.
Niu YN, Guo C, Guo XZ, Wei Q, Zhou X, Li M, Xia JN, Chen LP. Investigating the relationship between triglyceride-glucose index and intracranial arterial remodeling by high-resolution magnetic resonance imaging: a retrospective cross-sectional study. Quant Imaging Med Surg. 2023;13(12):8504–16.
Rosso C, Pires C, Corvol JC, Baronnet F, Crozier S, Leger A, Deltour S, Valabregue R, Amor-Sahli M, Lehéricy S. Hyperglycemia, insulin therapy, and critical penumbra affect acute stroke outcome: further insights from the INSULINFARCT trial. PLoS ONE. 2015;10(3):e0120230.
Renard CB, Kramer F, Johansson F, Lamharzi N, Tannock LR, von Herrath MG, Chait A, Bornfeldt KE. Diabetes and diabetes-related lipid abnormalities differentially affect the development and progression of atherosclerotic lesions. J Clin Investig. 2004;114(5):659–68.
Bloomgarden ZT. Inflammation and insulin resistance. Diabetes Care. 2003;26(6):1922–6.
Hurrle S, Hsu WH. Pathogenesis of oxidative stress in insulin resistance. Biomed J. 2017;40(5):257–62.
Mayer-Davis EJ, D’Agostino R Jr., Karter AJ, Haffner SM, Rewers MJ, Saad M, Bergman RN. Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. JAMA. 1998;279(9):669–74.
Farhadnejad H, Teymoori F, Mokhtari E, Mirmiran P, Azizi F. Higher dietary and lifestyle inflammatory index scores are associated with increased risk of insulin-related diseases in Iranian adults. Eur J Clin Nutr. 2022;76(11):1566–75.
Baek W, Lee JW, Lee HS, Han D, Choi SY, Chun EJ, Han HW, Park SH, Sung J, Jung HO, et al. Smokers and drinkers had higher triglyceride glycemic index than smokers and drinkers: a cross-sectional study in Korea. Lipids Health Dis. 2021;20(1):49.
Kan C, Silva N, Golden SH, Rajala U, Timonen M, Stahl D, Ismail K. A systematic review and meta-analysis of the association between depression and insulin resistance. Diabetes Care. 2013;36(2):480–9.
Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H. Prone to insulin resistance: insights into mechanisms and therapeutic strategies. Signal Transduct Target Ther. 2022;7(1):216.
[ad_2]
Source link